Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03426-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Ke Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, 3201 Hospital, Hanzhong, 723000, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Neuroblastoma, Janus Kinase 2, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, 3201 Hospital, Hanzhong, 723000, China.
- Department of Oncology, Kunming Children's Hospital, Kunming, 650000, China.
- Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi, 710038, PR China. wanglinfmmu@sina.com.
ORCID-Profile: Linlin Wang
Zitieren
APA
Wang, K., Li, Y., & Wang, L. (2025). Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03426-8
Vancouver
Wang K, Li Y, Wang L. Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03426-8
BibTeX
@article{Wang2025,
author = {Wang, Ke and Li, Ye and Wang, Linlin},
title = {Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03426-8}
}
EUVIMED